Trial Profile

A phase I, placebo controlled, dose escalation safety and pharmacokinetic study of Topical Endoxifen in healthy male volunteers

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 10 Sep 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

09 Jan 2019 Results presented in an Atossa Genetics Media Release.
26 Jun 2018 According to an Atossa Genetics media release, the company plans to announce preliminary results from this trial in the third quarter of 2018.
20 Jun 2018 According to an Atossa Genetics media release, the company has completed dosing and clinical visits in its Phase 1 study of its proprietary topical Endoxifen in men. It is proceeding with analysis of blood samples, data collection and analysis.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com